US drugmaker Pfizer and its German partner BioNTech have pledged to provide up to 75 million more doses of their vaccine to the EU in the second quarter of 2021, the German company’s chief financial officer Sierk Poetting said on Monday.
“We are working with pharmaceutical companies to ensure vaccines are delivered to Europeans,” the Commission President, Ursula von der Leyen wrote in a Twitter post, as on Sunday, she held a virtual meeting with the CEOs of vaccine producers, during which, s…
This story is part of New Europe’s Premium content.
| To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑ |
In this article:
